Trial record 6 of 147 for:    Open Studies | "African Americans"

Rheumatoid Arthritis Comorbidity: Bone Health in Men and African Americans

The recruitment status of this study is unknown because the information has not been verified recently.
Verified March 2011 by University of Nebraska.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
University of Nebraska
ClinicalTrials.gov Identifier:
NCT00595894
First received: January 7, 2008
Last updated: March 1, 2011
Last verified: March 2011
  Purpose

The objective of the proposed study is to assess bone health and determinants of bone health among select subpopulations of rheumatoid arthritis patients.


Condition
Rheumatoid Arthritis

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: RA Comorbidity: Bone Health in Men and African Americans

Resource links provided by NLM:


Further study details as provided by University of Nebraska:

Primary Outcome Measures:
  • Bone mineral density [ Time Frame: baseline and at 5 years disease ] [ Designated as safety issue: No ]

Biospecimen Retention:   Samples With DNA

Baseline sera and DNA collected


Estimated Enrollment: 3600
Study Start Date: July 2004
Estimated Study Completion Date: July 2010
Estimated Primary Completion Date: July 2010 (Final data collection date for primary outcome measure)
Groups/Cohorts
1
CLEAR enrollees include African American patients with early rheumatoid arthritis, as defined using ACR criteria
2
VARA enrollees will include male veterans with established RA diagnosed using ACR criteria

Detailed Description:

The overall hypothesis of this study is that osteopenia and/or osteoporosis are common among African Americans and men with rheumatoid arthritis and there are identifiable genetic and environmental factors contributing to the pathogenesis of bone loss in these groups.

The Specific Aims of the study are to:

  1. Determine baseline hip and lumbar spine bone density (BMD) values and osteopenia/osteoporosis prevalence among African American men and women with early RA and among male veterans with established RA.
  2. Identify environmental factors and candidate alleles, which confer increased risk of reduced baseline BMD loss over time among African American men and women with early RA and among male veterans with established RA.
  Eligibility

Ages Eligible for Study:   19 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

CLEAR enroll African American RA patients from 4 core academic centers in the Southeast U.S. VARA enroll RA patientss from participating VA medical centers.

Criteria

Inclusion Criteria:

  • Clinical diagnosis of rheumatoid arthritis per ACR guidelines

Exclusion Criteria:

  • Patients with diagnosis > 2yrs (CLEAR study)
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00595894

Contacts
Contact: Ted R Mikuls, MD, MSPH 402-559-7258 tmikuls@unmc.edu

Locations
United States, Nebraska
Omaha VA Medical Center Recruiting
Omaha, Nebraska, United States, 68105
Contact: Ted R Mikuls, MD, MSPH     402-559-7258     tmikuls@unmc.edu    
Omaha Veterans Affairs Medical Center Recruiting
Omaha, Nebraska, United States, 68105
Contact: Ted R Mikuls, MD, MSPH     402-559-8846     tmikuls@unmc.edu    
Sponsors and Collaborators
University of Nebraska
Investigators
Principal Investigator: Ted R Mikuls, MD, MSPH University of Nebraska
  More Information

Additional Information:
No publications provided

Responsible Party: Ted Mikuls, MD, MSPH, University of Nebraska Medical Center
ClinicalTrials.gov Identifier: NCT00595894     History of Changes
Other Study ID Numbers: 028-03-ET, 5K23AR050004-04
Study First Received: January 7, 2008
Last Updated: March 1, 2011
Health Authority: United States: Institutional Review Board

Keywords provided by University of Nebraska:
rheumatoid arthritis
African Americans
osteopenia
osteoporosis
bone mineral density

Additional relevant MeSH terms:
Arthritis
Arthritis, Rheumatoid
Joint Diseases
Musculoskeletal Diseases
Rheumatic Diseases
Connective Tissue Diseases
Autoimmune Diseases
Immune System Diseases

ClinicalTrials.gov processed this record on May 23, 2013